Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Convertible Debt (2011 - 2015)

Updated

Vistagen Therapeutics (VTGN) reported Convertible Debt of $85,100 for fiscal Q3 2016 (quarter ended Dec 31, 2015), down 30.0% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Convertible Debt (2011 - 2015) Analysis & Trends

At the end of FY2015 (ended Mar 31, 2015), Vistagen Therapeutics posted Convertible Debt of $10.97 million.

  • Convertible Debt has a four-year compound annual growth rate of 22.9% (FY2011 to FY2015).
  • By fiscal year, Convertible Debt came in at $4.81 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 85,100.00
Sep 30, 2015 121,500.00
Mar 31, 2015 10.97 Mn
Mar 31, 2011 4.81 Mn
API Access

Vistagen Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VTGN&period=max&api_key=YOUR_API_KEY